vs

Side-by-side financial comparison of Caesars Entertainment (CZR) and Quest Diagnostics (DGX). Click either name above to swap in a different company.

Quest Diagnostics is the larger business by last-quarter revenue ($2.9B vs $2.9B, roughly 1.0× Caesars Entertainment). Quest Diagnostics runs the higher net margin — 9.7% vs -2.9%, a 12.6% gap on every dollar of revenue. On growth, Quest Diagnostics posted the faster year-over-year revenue change (9.2% vs 2.7%). Over the past eight quarters, Quest Diagnostics's revenue compounded faster (9.9% CAGR vs 0.7%).

Caesars Entertainment, Inc., formerly Eldorado Resorts, Inc., is an American hotel and casino entertainment company founded and based in Reno, Nevada, that operates more than 50 properties. Eldorado Resorts acquired Caesars Entertainment Corporation and changed its own name to Caesars Entertainment on July 20, 2020.

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

CZR vs DGX — Head-to-Head

Bigger by revenue
DGX
DGX
1.0× larger
DGX
$2.9B
$2.9B
CZR
Growing faster (revenue YoY)
DGX
DGX
+6.4% gap
DGX
9.2%
2.7%
CZR
Higher net margin
DGX
DGX
12.6% more per $
DGX
9.7%
-2.9%
CZR
Faster 2-yr revenue CAGR
DGX
DGX
Annualised
DGX
9.9%
0.7%
CZR

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CZR
CZR
DGX
DGX
Revenue
$2.9B
$2.9B
Net Profit
$-83.0M
$281.0M
Gross Margin
Operating Margin
17.4%
15.4%
Net Margin
-2.9%
9.7%
Revenue YoY
2.7%
9.2%
Net Profit YoY
15.3%
12.0%
EPS (diluted)
$-0.48
$2.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CZR
CZR
DGX
DGX
Q1 26
$2.9B
$2.9B
Q4 25
$2.9B
$2.8B
Q3 25
$2.9B
$2.8B
Q2 25
$2.9B
$2.8B
Q1 25
$2.8B
$2.7B
Q4 24
$2.8B
$2.6B
Q3 24
$2.9B
$2.5B
Q2 24
$2.8B
$2.4B
Net Profit
CZR
CZR
DGX
DGX
Q1 26
$-83.0M
$281.0M
Q4 25
$-250.0M
$245.0M
Q3 25
$-55.0M
$245.0M
Q2 25
$-82.0M
$282.0M
Q1 25
$-115.0M
$220.0M
Q4 24
$11.0M
$222.0M
Q3 24
$-9.0M
$226.0M
Q2 24
$-122.0M
$229.0M
Gross Margin
CZR
CZR
DGX
DGX
Q1 26
Q4 25
32.4%
Q3 25
33.7%
Q2 25
34.2%
Q1 25
32.5%
Q4 24
32.7%
Q3 24
32.6%
Q2 24
33.5%
Operating Margin
CZR
CZR
DGX
DGX
Q1 26
17.4%
15.4%
Q4 25
11.4%
13.8%
Q3 25
17.9%
13.7%
Q2 25
18.1%
15.9%
Q1 25
17.5%
13.0%
Q4 24
23.9%
13.8%
Q3 24
22.4%
13.3%
Q2 24
17.9%
14.8%
Net Margin
CZR
CZR
DGX
DGX
Q1 26
-2.9%
9.7%
Q4 25
-8.6%
8.7%
Q3 25
-1.9%
8.7%
Q2 25
-2.8%
10.2%
Q1 25
-4.1%
8.3%
Q4 24
0.4%
8.5%
Q3 24
-0.3%
9.1%
Q2 24
-4.3%
9.6%
EPS (diluted)
CZR
CZR
DGX
DGX
Q1 26
$-0.48
$2.24
Q4 25
$-1.22
$2.18
Q3 25
$-0.27
$2.16
Q2 25
$-0.39
$2.47
Q1 25
$-0.54
$1.94
Q4 24
$0.04
$1.95
Q3 24
$-0.04
$1.99
Q2 24
$-0.56
$2.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CZR
CZR
DGX
DGX
Cash + ST InvestmentsLiquidity on hand
$867.0M
$393.0M
Total DebtLower is stronger
$5.7B
Stockholders' EquityBook value
$7.7B
Total Assets
$16.7B
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CZR
CZR
DGX
DGX
Q1 26
$867.0M
$393.0M
Q4 25
$887.0M
$420.0M
Q3 25
$836.0M
$432.0M
Q2 25
$982.0M
$319.0M
Q1 25
$884.0M
$188.0M
Q4 24
$866.0M
$549.0M
Q3 24
$802.0M
$764.0M
Q2 24
$830.0M
$271.0M
Total Debt
CZR
CZR
DGX
DGX
Q1 26
$5.7B
Q4 25
$11.9B
$5.2B
Q3 25
$11.9B
$5.2B
Q2 25
$12.3B
$5.2B
Q1 25
$12.3B
$5.9B
Q4 24
$12.3B
$5.6B
Q3 24
$12.7B
$5.6B
Q2 24
$12.4B
$3.8B
Stockholders' Equity
CZR
CZR
DGX
DGX
Q1 26
$7.7B
Q4 25
$3.5B
$7.2B
Q3 25
$3.8B
$7.3B
Q2 25
$3.9B
$7.2B
Q1 25
$4.1B
$6.9B
Q4 24
$4.2B
$6.8B
Q3 24
$4.2B
$6.8B
Q2 24
$4.3B
$6.6B
Total Assets
CZR
CZR
DGX
DGX
Q1 26
$16.7B
Q4 25
$31.6B
$16.2B
Q3 25
$31.9B
$16.2B
Q2 25
$32.5B
$16.0B
Q1 25
$32.4B
$15.8B
Q4 24
$32.6B
$16.2B
Q3 24
$33.0B
$16.1B
Q2 24
$33.1B
$13.9B
Debt / Equity
CZR
CZR
DGX
DGX
Q1 26
0.74×
Q4 25
3.40×
0.72×
Q3 25
3.15×
0.71×
Q2 25
3.15×
0.72×
Q1 25
3.04×
0.85×
Q4 24
2.96×
0.83×
Q3 24
3.04×
0.83×
Q2 24
2.89×
0.58×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CZR
CZR
DGX
DGX
Operating Cash FlowLast quarter
$278.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
3.9%
Cash ConversionOCF / Net Profit
0.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CZR
CZR
DGX
DGX
Q1 26
$278.0M
Q4 25
$304.0M
$465.0M
Q3 25
$318.0M
$563.0M
Q2 25
$462.0M
$544.0M
Q1 25
$218.0M
$314.0M
Q4 24
$309.0M
$464.0M
Q3 24
$232.0M
$356.0M
Q2 24
$454.0M
$360.0M
Free Cash Flow
CZR
CZR
DGX
DGX
Q1 26
Q4 25
$147.0M
$307.0M
Q3 25
$123.0M
$419.0M
Q2 25
$232.0M
$436.0M
Q1 25
$-5.0M
$197.0M
Q4 24
$30.0M
$341.0M
Q3 24
$-192.0M
$250.0M
Q2 24
$125.0M
$268.0M
FCF Margin
CZR
CZR
DGX
DGX
Q1 26
Q4 25
5.0%
10.9%
Q3 25
4.3%
14.9%
Q2 25
8.0%
15.8%
Q1 25
-0.2%
7.4%
Q4 24
1.1%
13.0%
Q3 24
-6.7%
10.0%
Q2 24
4.4%
11.2%
Capex Intensity
CZR
CZR
DGX
DGX
Q1 26
3.9%
Q4 25
5.4%
5.6%
Q3 25
6.8%
5.1%
Q2 25
7.9%
3.9%
Q1 25
8.0%
4.4%
Q4 24
10.0%
4.7%
Q3 24
14.8%
4.3%
Q2 24
11.6%
3.8%
Cash Conversion
CZR
CZR
DGX
DGX
Q1 26
0.99×
Q4 25
1.90×
Q3 25
2.30×
Q2 25
1.93×
Q1 25
1.43×
Q4 24
28.09×
2.09×
Q3 24
1.58×
Q2 24
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CZR
CZR

Casino$1.7B58%
Hotel$487.0M17%
Food and beverage$424.0M15%
Other$293.0M10%

DGX
DGX

Segment breakdown not available.

Related Comparisons